AI is the only way to go for mold surveillance! Hope to see results from implementation of this tool soon. Much needed.

This study is so thought provoking

Hot off the press - late breaking data from Tori Hall NCIC demonstrating similiar immunogenicity from two different vax strategies and no incremental benefit of second dose. #ESCMIDGlobal2024 #TxID

True Aussies 🇦🇺 sourcing out Melbourne roasted coffee ☕️ ESCMID NCIC Michelle Yong

#ECCMID2024 NCIC A comprehensive clinical approach to switching mould treatment by fungal expert monica slavin; consider mixed dual infection, breakthrough IMI, treatment change based on early vs late breakthrough.

Pf monica slavin NCIC is 🔝🔝🔝! Thanks for a great talk!
This is one of the important message to take home!
#ESCMIDGlobal2024

Thanks Kas NCAS_Australia - important trial findings of reduced #COVID and lots of further research to be done - but adds to all our other preventative measures esp in immunecompromised NCIC ESCMID

🔥BREAKING NEWS: Michelle Yong presented the late breaker abstract of the NCIC MRFF investigator initiated #CSMART Trial at #ESCMIDGlobal2024 in Barcelona today. This DB RCT showed that intranasal interferon is safe and effective in reducing the acquisition of COVID infection…

Great work and presentation led by Michelle Yong, team effort and collaborators to complete this important placebo controlled RCT of IFN alpha spray reducing COVID-19 in patients with cancer (C-SMART trial) monica slavin Rach W NCAS_Australia

Congratulations Ben Teh for a tour de force on vaccination strategies and increasing uptake in immunocompromised patients - a full house in Hall C! NCIC ESCMID

Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination

✅ Just Accepted
🔓 Open Access
🔗 bit.ly/3TUHSIQ

congratulations Tori Hall

ESGICH (the ESCMID Study Group for Infections in Compromised Host) is awarding 4 trainee and young investigators awards. Congratulations!!

Congratulations to Tori Hall who will presenting in Hall C on 29 April 11am-12pm.

Thank you ! Really looking forward to presenting ESCMID NCIC Ben Teh Michelle Yong monica slavin Dr Olivia Smibert

NCIC had a hugely successful #ICHS2024 with A/Prof Michelle Yong being announced as the council Vice President and Dr Abby Douglas being awarded best poster presentation. See you all again next year in Houston, Texas with Dr Roy Chemaly!

Thanks Michael Ison, MD MS for posting with those links. So many important trials published in the space of transplant CMV strategies in the last 6 months. A must read - see links #ICHS #TID ICHS-Global NCIC Dr Roy Chemaly

🚨 Looking to help plan ideas for ESGICH to propose for ECCMID 2025? 🚨

1. Sign up to join a planning group meeting April 29 12:30pm CET: forms.gle/vmjqR2FVM3yuus…

2. Have ideas for proposals? Submit them here: forms.gle/c5vqYfR734ZTZd…

In a large prospective cohort of 1,975 SOT recipientes, we showed that early treatment and ≥3 vaccine doses were associated with reduced severity. Lung tx was associated with worse outcomes Deepali Kumar Tina Marinelli Tori Hall Mittal Ankit 👨‍⚕️
doi.org/10.1016/j.ajt.…

Editorial CAR-T cell therapy pts & COVID-19 vax sciencedirect.com/science/articl…
Improved COVID-19 Ab response w/ 4 vaccines post cellular therapy, BCMA RRMM pts superior responses. Qu remain re: hybrid immunity, scheduling, optimal dosing, type post procedure NCIC Transplantation and Cellular Therapy Journal

Happy IWD! More than 80% of the NCIC is comprised of women, so we want to highlight how proud we are of our team and their achievements!

#IWD2024 #InspireInclusion #NCIC